Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

O-GlcNAc transferase Inhibitors

O-GlcNAc transferase inhibitors belong to a specific chemical class of compounds that are meticulously designed to modulate the activity of O-GlcNAc transferase, an enzyme responsible for catalyzing the addition of O-linked N-acetylglucosamine (O-GlcNAc) to serine and threonine residues of target proteins. This post-translational modification plays a critical role in cellular processes such as protein folding, stability, and signaling. These inhibitors are thoughtfully crafted molecules engineered to interact with O-GlcNAc transferase, influencing its normal function. Through these interactions, they might impact various cellular processes associated with protein modification, cellular signaling, and metabolic pathways, without directly altering its catalytic sites or its involvement in protein O-GlcNAcylation. The design of O-GlcNAc transferase inhibitors is grounded in a comprehensive understanding of the structural and functional attributes of the enzyme. Typically developed using advanced chemical synthesis methods and informed by insights from biochemistry and cellular signaling pathways, these inhibitors are characterized by their ability to selectively bind to O-GlcNAc transferase. This selectivity enables focused modulation of cellular pathways that rely on the activity of this specific enzyme. By systematically investigating the effects of O-GlcNAc transferase inhibition, researchers gain insights into its intricate role in regulating protein modifications and cellular responses. The development and utilization of O-GlcNAc transferase inhibitors contribute to advancing our understanding of the complex interplay between post-translational modifications and cellular dynamics, offering insights into the fundamental molecular mechanisms that govern protein regulation and contribute to cellular responses to changes in O-GlcNAc transferase activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside

3554-93-6sc-203427
sc-203427A
100 mg
1 g
$350.00
$3122.00
2
(0)

A chemical compound that functions as an inhibitor of O-GlcNAc transferase, a key enzyme involved in post-translational modification processes. By inhibiting O-GlcNAc transferase, this compound disrupts its activity, potentially influencing various cellular pathways.

(Z)-Pugnac

132489-69-1sc-204415A
sc-204415
5 mg
10 mg
$220.00
$373.00
3
(1)

Acts as a competitive inhibitor of O-GlcNAcase (OGA), preventing the removal of O-GlcNAc from proteins, leading to increased O-GlcNAcylation levels.

Thiamet G

1009816-48-1sc-224307
sc-224307A
1 mg
5 mg
$51.00
$94.00
1
(2)

Inhibits OGA by binding to its catalytic site, resulting in elevated O-GlcNAc levels on target proteins due to reduced removal of O-GlcNAc.

Azaserine

115-02-6sc-29063
sc-29063A
50 mg
250 mg
$306.00
$906.00
15
(3)

An inhibitor of the hexosamine biosynthesis pathway (HBP), decreases the availability of UDP-GlcNAc, reducing the substrate for O-GlcNAc transferase.

Streptozotocin (U-9889)

18883-66-4sc-200719
sc-200719A
1 g
5 g
$110.00
$510.00
152
(7)

Toxic to beta cells and inhibits glucose metabolism, affecting the hexosamine biosynthesis pathway and subsequently O-GlcNAcylation.

Alloxan monohydrate

2244-11-3sc-254940
10 g
$53.00
(2)

Induces oxidative stress and can affect glucose metabolism, potentially impacting the hexosamine biosynthesis pathway and O-GlcNAcylation.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

Can modulate O-GlcNAcylation levels by affecting the O-GlcNAc transferase and O-GlcNAcase enzymes through indirect mechanisms.

6-Diazo-5-oxo-L-norleucine

157-03-9sc-227078
sc-227078A
sc-227078B
sc-227078C
5 mg
25 mg
100 mg
250 mg
$82.00
$285.00
$908.00
$2152.00
(0)

Inhibits multiple pathways, including hexosamine biosynthesis, which can lead to alterations in O-GlcNAcylation levels.